PainChek Limited (ASX:PCK) Completes AUD $5.1 Million Entitlement Offer
PainChek Limited completes a successful Entitlement Offer, raising AUD $5.1 million for market expansion and product development.
PainChek Limited completes a successful Entitlement Offer, raising AUD $5.1 million for market expansion and product development.
Patrys Limited (ASX:PAB) secures $1.285 million in R&D Tax Incentive funding to advance its therapeutic antibody development initiatives.
Chimeric Therapeutics (ASX:CHM) advances its ADVENT-AML Phase 1B trial for newly diagnosed AML patients.
Invex Therapeutics Limited (ASX:IXC) reports significant findings on Exenatide’s efficacy in neuronal cell survival using a 3D brain model for Alzheimer’s Disease.
Aura Energy (ASX:AEE) has reported a 49% increase in Ore Reserves to 62.8Mt at the Tiris Uranium Project, enhancing project viability.
4DMedical Limited (ASX:4DX) has secured a contract with University of Chicago Medicine to enhance lung imaging and care.
INOVIQ Limited (ASX:IIQ) announces successful proof of concept for exosome therapy targeting breast cancer.
Aurora Energy Metals (ASX:1AE) announces significant uranium recovery improvements in its Aurora Uranium Project, achieving rates over 85%.
Venus Metals Corporation (ASX: VMC) reports promising exploration results from Copper Hills and Youanmi projects.
Maximus Resources Limited (ASX:MXR) completes follow-up drill program at Eagles Nest gold deposit; assay results expected in January 2025.